We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Antibiotic Resistant Bacteria Succumb to Treatment with Unique Natural Clay

By LabMedica International staff writers
Posted on 07 Feb 2016
A team of Canadian medical microbiologists has demonstrated the potential use of a unique type of natural clay for treating pathogenic bacteria that have become resistant to the commonly used antibiotics.

Medicinal and therapeutic use of mineral products has impacted human health for thousands of years, and pure clay minerals, such as smectite and illite, are nanomaterials of geological origin. More...
The intentional consumption of earth materials, such as clays, by humans and animals is known as geophagy, a complex behavior, largely attributed to religious beliefs, cultural practices, psychological disorders, cosmetics, dietary/nutritional needs, and medicinal benefits. Early research focused on the extraordinary adsorptive properties of clay minerals and the health benefits recognized in aiding digestive processes and cleansing and protecting the skin. Due to the small particle size (less than two micrometers), these natural geological products have a vast surface area (hundreds of square meters per gram of clay) with high concentrations of ions and compounds located on the surfaces. Despite the clear, beneficial effects on human health related to ridding the body of foreign substances, few studies have investigated the antibacterial properties of clay minerals.

Investigators at the University of British Columbia (Canada) worked with Kisameet clay, which was found in a shallow five-acre granite basin located about 400 kilometers north of Vancouver, Canada. This material was valued by indigenous peoples for its therapeutic properties for treatment of a wide variety of disorders including ulcerative colitis, duodenal ulcer, arthritis, neuritis, phlebitis, skin irritation, and burns.

In particular the investigators examined the effect of the clay on the bacteria comprising the ESKAPE group (Enterococcus faecium, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species), which have developed antibiotic resistance and cause the majority of nosocomial infections.

They reported in the January 26, 2016, online edition of the journal mBio that in vitro tests of the clay suspended in water showed that it was capable of killed 16 strains of ESKAPE bacteria from various sources.

"Infections caused by ESKAPE bacteria are essentially untreatable and contribute to increasing mortality in hospitals," said senior author Dr. Julian Davies, professor emeritus in microbiology at the University of British Columbia. "After 50 years of over-using and misusing antibiotics, ancient medicinals and other natural mineral-based agents may provide new weapons in the battle against multidrug-resistant pathogens."

Related Links:

University of British Columbia



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Staining System
RAL DIFF-QUIK
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.